ICU Medical (ICUI) Tops Q3 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Piper Jaffray Reiterates Overweight Rating on ICU Medical (ICUI) Following 3Q Beat
November 6, 2015 10:10 AM ESTPiper Jaffray reiterated an Overweight rating on ICU Medical (NASDAQ: ICUI), and raised the price target to $129.00 (from $124.00), following the company's 3Q earnings report. ICUI reported 3Q15 sales and EPS of $86.0M and $1.00, which compared to consensus of $81.3M and $0.84. Two key highlights in the quarter were ICUIs continued strength in OEM sales and the long-term supply... More



